Register free for our breaking news email alerts with analysis and cutting edge commentary from our award winning team. Registration only takes a minute.

AXA Framlington Health R Inc

Ranked 23 out of 27 in - Pharmaceuticals & Health Care over 12 months
All calculations are in GBP unless stated

Managed by

Dani Saurymper

Objective

To achieve capital growth through investment in healthcare and medical services and product companies worldwide. Investment will be in producers of pharmaceuticals, biotechnology firms, medical device and instrument manufacturers, distributors of healthcare products, care providers and managers, and other healthcare services companies.

Showing fund performance in United Kingdom View performance globally

Performance

Pharmaceuticals & Health Care over : 31/03/2017 - 31/03/2018

Total Return

Quarterly Performance

to 31/03/2018 Annual Q1 Q2 Q3 Q4
2018 -6.5%
2017 4.3% 8.1% 0.2% -4.1% 0.5%
2016 7.0% -7.2% 10.1% 6.4% -1.6%
2015 11.4% 15.4% -4.1% -8.9% 10.6%
2014 29.5% 3.5% 3.6% 8.6% 11.1%
2013 34.6% 20.9% 0.9% 3.3% 6.8%
2012 11.2% 7.0% 3.5% 3.8% -3.2%
2011 5.3% 3.4% 5.2% -8.9% 6.3%
2010 16.2% 15.1% -9.3% 1.9% 9.3%
2009 15.2% -4.3% 1.6% 13.1% 4.7%
2008 -7.7% -13.7% 3.6% 4.7% -1.4%
2007 8.0% 2.7% 2.0% 2.9% 0.1%
2006 -11.9% 4.5% -15.4% 0.1% -0.3%
2005 15.2% -6.3% 11.8% 8.9% 1.0%
2004 3.4% 5.0% 1.4% -6.7% 4.0%
2003 32.9% 0.3% 19.8% 7.1% 3.3%
2002 -43.5% -10.2% -25.6% -16.2% 0.9%
2001 -14.7% -28.6% 28.5% -26.2% 26.1%
2000 116.6% 49.8% 30.5% 28.9% -14.1%
1999 44.7% -8.2% 5.7% 3.2% 44.3%
1998 -7.3% 9.2% -7.2% -19.9% 14.1%
1997 9.8% 4.1% 2.2% 14.8% -10.1%
1996 7.4% 15.6% 3.8% -3.2% -7.5%
1995 92.2% 9.3% 12.0% 26.1% 24.5%
1994 -11.9% -2.8% -18.0% 11.6% -1.0%
1993 7.0% -17.5% 10.7% 5.9% 10.6%
1992 20.5% -0.8% -18.0% 8.8% 36.3%
1991 114.8% 46.3% 7.1% 21.7% 12.6%
1990 -1.3% -2.8% 11.8% -15.2% 7.1%
1989 34.8% 14.0% 8.3% 9.3% -0.1%
1988 6.6% 5.9% 6.2% -1.2% -4.1%
1987 5.0% -32.3%

Month by Month Performance

Returns Vs Risk

Registered For Sale In

  1. United Kingdom

Fund Info

  • Launch date24/04/1987
  • Share Class size449Mn
  • Base currencyGBP
  • ISIN GB0005753719

Purchase Info

  • Min. initial investment1,000
  • Min. regular additional investment50

Charges

  • Annual management1.50%
  • Initial investment1.5

Related News

AXA IM's Saurymper: don't be afraid of Clinton biotech stance

The manager of the AXA Framlington Health fund analyses what the US election could mean for the healthcare sector.

AXA IM hires Barclays man to run healthcare funds

AXA Investment Managers has hired Dani Saurymper to manage its £579 million AXA Framlington Health fund and the $229 million (£156 million) AXA WF Framlington Health fund.

Gemma Game to exit AXA Investment Managers

Game was head of healthcare at the firm and had managed the AXA Framlington Health fund since July 2011.

AAA-rated Bowie: corporate bonds could fall up to 40%

Chris Bowie, head of credit at Ignis Asset Management, believes corporate bonds have limited upside and could see a capital loss of up to 40% if real gilt yields adjust.

GLG: why the tech sector is set to face a big battle

GLG’s managers Anthony Burton and Philip Pearson believe the technology sector is set to face ‘significant disruption’ due to Amazon’s loss-leading approach with its new Kindle Fire tablet.

Biotechnology won the 2000 race

Believers in the biotechnological revolution were the biggest winners last year with Anthony Milford’s Framlington Health at the top of Lipper Hindsight’s performance table.

Unit trusts struggle to keep heads above water in 2000

Almost half of the 1763 authorised unit trusts tracked by Lipper Hindsight have failed to make money for their investors this year, figures to the end of September show.

Performance is for the period shown (month end to month end, bid/bid, gross income reinvested, calculated in the currency and currencies indicated).